Search

Search Constraints

You searched for: Author/Creator Monard, Adrien

Search Results

1. Access to innovation through the national early access program and clinical trials for patients with malignant melanoma. Issue 13 (25th March 2021)

2. Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years. (May 2021)

4. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19). (December 2020)

5. Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019. Issue 8 (7th July 2022)